Pentazocine versus combined Pentazocine and Diclofenac for Pain Relief in the First 24 Hours after Caesarean Section: A Randomized Controlled Study.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201607001703323

Enrollment

126

Registered

2016-07-01

Start date

2014-11-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy and Childbirth Post-Caesarean section analgesia

Interventions

Pentazocine plus sterile water for injection

Pentazocine plus diclofenac

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: consenting low risk parturients who had either elective or emergency caesarean section Had spinal anaesthesia Conscious

Exclusion criteria

Exclusion criteria: Had general anaesthesia Had stillbirth History of allergy to pentazocine or diclofenac. History of severe obstetric haemorrhage Delirium Preexisting opioid dependency Sickle cell haemoglobinopathy Peptic ulcer disease Psychiatric illness Illiteracy and Declined consent to participate in the study despite adequate counselling.

Design outcomes

Primary

Measure	Time frame
Postoperative pain control	—

Secondary

Measure	Time frame
patient satisfaction and maternal and neonatal adverse outcomes.	—

Countries

Nigeria

Contacts

Public ContactLeonard Ajah

Lecturer/Honorary Consultant

leookpanku@yahoo.com+2348033920789

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026